HLN
Price
$10.13
Change
+$0.03 (+0.30%)
Updated
Dec 26, 04:59 PM (EDT)
Capitalization
44.78B
61 days until earnings call
Intraday BUY SELL Signals
ZTS
Price
$126.23
Change
+$0.74 (+0.59%)
Updated
Dec 26 closing price
Capitalization
55.3B
52 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

HLN vs ZTS

Header iconHLN vs ZTS Comparison
Open Charts HLN vs ZTSBanner chart's image
Haleon
Price$10.13
Change+$0.03 (+0.30%)
Volume$33.34K
Capitalization44.78B
ZOETIS
Price$126.23
Change+$0.74 (+0.59%)
Volume$3.23M
Capitalization55.3B
HLN vs ZTS Comparison Chart in %
HLN
Daily Signal:
Gain/Loss:
ZTS
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
HLN vs. ZTS commentary
Dec 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HLN is a Buy and ZTS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 27, 2025
Stock price -- (HLN: $10.10 vs. ZTS: $125.49)
Brand notoriety: HLN: Not notable vs. ZTS: Notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: HLN: 57% vs. ZTS: 45%
Market capitalization -- HLN: $44.78B vs. ZTS: $55.3B
HLN [@Pharmaceuticals: Generic] is valued at $44.78B. ZTS’s [@Pharmaceuticals: Generic] market capitalization is $55.3B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HLN’s FA Score shows that 1 FA rating(s) are green whileZTS’s FA Score has 2 green FA rating(s).

  • HLN’s FA Score: 1 green, 4 red.
  • ZTS’s FA Score: 2 green, 3 red.
According to our system of comparison, ZTS is a better buy in the long-term than HLN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HLN’s TA Score shows that 4 TA indicator(s) are bullish while ZTS’s TA Score has 4 bullish TA indicator(s).

  • HLN’s TA Score: 4 bullish, 4 bearish.
  • ZTS’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, HLN is a better buy in the short-term than ZTS.

Price Growth

HLN (@Pharmaceuticals: Generic) experienced а +2.85% price change this week, while ZTS (@Pharmaceuticals: Generic) price change was +2.65% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +5.98%. For the same industry, the average monthly price growth was +12.50%, and the average quarterly price growth was +30.15%.

Reported Earning Dates

HLN is expected to report earnings on Feb 25, 2026.

ZTS is expected to report earnings on Feb 17, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (+5.98% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZTS($55.3B) has a higher market cap than HLN($44.8B). HLN has higher P/E ratio than ZTS: HLN (22.38) vs ZTS (21.13). HLN YTD gains are higher at: 7.731 vs. ZTS (-21.956). ZTS has higher annual earnings (EBITDA): 4.04B vs. HLN (2.71B). ZTS has more cash in the bank: 2.08B vs. HLN (676M). ZTS has less debt than HLN: ZTS (7.27B) vs HLN (8.45B). HLN has higher revenues than ZTS: HLN (11B) vs ZTS (9.4B).
HLNZTSHLN / ZTS
Capitalization44.8B55.3B81%
EBITDA2.71B4.04B67%
Gain YTD7.731-21.956-35%
P/E Ratio22.3821.13106%
Revenue11B9.4B117%
Total Cash676M2.08B33%
Total Debt8.45B7.27B116%
FUNDAMENTALS RATINGS
ZTS: Fundamental Ratings
ZTS
OUTLOOK RATING
1..100
11
VALUATION
overvalued / fair valued / undervalued
1..100
32
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
19
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
86
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HLNZTS
RSI
ODDS (%)
Bearish Trend 3 days ago
48%
Bullish Trend 3 days ago
69%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
48%
Bearish Trend 3 days ago
60%
Momentum
ODDS (%)
Bullish Trend 3 days ago
57%
Bullish Trend 3 days ago
52%
MACD
ODDS (%)
Bullish Trend 3 days ago
56%
Bullish Trend 3 days ago
59%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
53%
Bullish Trend 3 days ago
58%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
49%
Bullish Trend 3 days ago
56%
Advances
ODDS (%)
Bullish Trend 4 days ago
56%
Bullish Trend 12 days ago
55%
Declines
ODDS (%)
Bearish Trend 18 days ago
50%
Bearish Trend 18 days ago
59%
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
47%
Aroon
ODDS (%)
Bearish Trend 3 days ago
35%
Bearish Trend 3 days ago
54%
View a ticker or compare two or three
Interact to see
Advertisement
HLN
Daily Signal:
Gain/Loss:
ZTS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ACGR66.821.03
+1.57%
American Century Large Cap Growth ETF
RAYJ33.500.25
+0.75%
Rayliant SMDAM Japan Equity ETF
FFLG30.360.08
+0.26%
Fidelity Fundamental Large Cap Gr ETF
TSEC26.20N/A
N/A
Touchstone Securitized Income ETF
VSGX71.82-0.03
-0.04%
Vanguard ESG International Stock ETF

HLN and

Correlation & Price change

A.I.dvisor indicates that over the last year, HLN has been loosely correlated with HLNCF. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if HLN jumps, then HLNCF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLN
1D Price
Change %
HLN100%
-0.10%
HLNCF - HLN
49%
Loosely correlated
+0.40%
TAK - HLN
38%
Loosely correlated
+0.78%
ZTS - HLN
32%
Poorly correlated
+1.58%
BHC - HLN
25%
Poorly correlated
-1.91%
COLL - HLN
25%
Poorly correlated
+1.49%
More

ZTS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZTS has been loosely correlated with ELAN. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ZTS jumps, then ELAN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZTS
1D Price
Change %
ZTS100%
+1.58%
ELAN - ZTS
47%
Loosely correlated
+0.72%
VTRS - ZTS
38%
Loosely correlated
+1.83%
PAHC - ZTS
38%
Loosely correlated
+0.94%
AMPH - ZTS
36%
Loosely correlated
+1.36%
PRGO - ZTS
35%
Loosely correlated
+0.51%
More